STEPHEN P SQUINTO Insider Trading Transactions
Get free email notifications about insider trading for STEPHEN P SQUINTO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEPHEN P SQUINTO. STEPHEN P SQUINTO is EVP & Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP & Head of Research & Devel in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Chief Global Ops. Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Global Ops. Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Research & Development in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Research and Development in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec VP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec VP, Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec. VP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP& Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP/Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in Chemomab Therapeutics Ltd. ($ANCN) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in SpringWorks Therapeutics, Inc. ($SWTX) and Head of Research and Dev in Passage BIO, Inc. ($PASG).
Latest Insider Trading Transactions of STEPHEN P SQUINTO
Sentiment: All, ALXN, BOLD, ANCN, PASG, SWTX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.02 | 1,827 | 38,404 | 36,248 | 38.1 K to 36.2 K (-4.80 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.03 | 1,073 | 22,565 | 38,075 | 39.1 K to 38.1 K (-2.74 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.10 | 5,300 | 111,830 | 39,148 | 44.4 K to 39.1 K (-11.92 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.11 | 100 | 2,111 | 44,448 | 44.5 K to 44.4 K (-0.22 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.14 | 300 | 6,342 | 44,548 | 44.8 K to 44.5 K (-0.67 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.15 | 700 | 14,805 | 44,848 | 45.5 K to 44.8 K (-1.54 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.16 | 700 | 14,812 | 45,548 | 46.2 K to 45.5 K (-1.51 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.95 | 1,267 | 26,545 | 46,248 | 47.5 K to 46.2 K (-2.67 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.00 | 7,900 | 165,900 | 47,515 | 55.4 K to 47.5 K (-14.26 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.01 | 3,433 | 72,127 | 55,415 | 58.8 K to 55.4 K (-5.83 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.01 | 587 | 12,333 | 58,848 | 59.4 K to 58.8 K (-0.99 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.02 | 400 | 8,408 | 59,435 | 59.8 K to 59.4 K (-0.67 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.04 | 900 | 18,936 | 59,835 | 60.7 K to 59.8 K (-1.48 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.04 | 500 | 10,521 | 60,735 | 61.2 K to 60.7 K (-0.82 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.05 | 108 | 2,273 | 61,235 | 61.3 K to 61.2 K (-0.18 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.00 | 15,095 | 150,950 | 61,343 | 46.2 K to 61.3 K (+32.64 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.00 | 29,905 | 299,050 | 46,248 | 16.3 K to 46.2 K (+182.98 %) |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 20.38 | 8,000 | 163,040 | 8,000 | |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Grant | A | 0.00 | 4,000 | 0 | 15,876 | 11.9 K to 15.9 K (+33.68 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.15 | 3,150 | 79,223 | 11,876 | 15 K to 11.9 K (-20.96 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.20 | 100 | 2,520 | 15,026 | 15.1 K to 15 K (-0.66 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.22 | 1,150 | 29,003 | 15,126 | 16.3 K to 15.1 K (-7.07 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.23 | 100 | 2,523 | 16,276 | 16.4 K to 16.3 K (-0.61 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.24 | 400 | 10,096 | 16,376 | 16.8 K to 16.4 K (-2.38 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.24 | 540 | 13,630 | 16,776 | 17.3 K to 16.8 K (-3.12 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.00 | 9,000 | 225,000 | 17,316 | 26.3 K to 17.3 K (-34.20 %) |
Dec 21 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Buy | J | 0.00 | 467 | 0 | 12,343 | 11.9 K to 12.3 K (+3.93 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.00 | 1,810 | 45,250 | 26,316 | 28.1 K to 26.3 K (-6.44 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Option Exercise | M | 2.38 | 11,250 | 26,719 | 0 | |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Option Exercise | M | 2.38 | 1,875 | 4,453 | 0 | |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.77 | 600 | 12,462 | 28,126 | 28.7 K to 28.1 K (-2.09 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.75 | 100 | 2,075 | 28,726 | 28.8 K to 28.7 K (-0.35 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.76 | 411 | 8,532 | 28,826 | 29.2 K to 28.8 K (-1.41 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.78 | 533 | 11,076 | 29,237 | 29.8 K to 29.2 K (-1.79 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.95 | 567 | 11,879 | 29,770 | 30.3 K to 29.8 K (-1.87 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.90 | 4,341 | 90,727 | 30,337 | 34.7 K to 30.3 K (-12.52 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 21.00 | 659 | 13,839 | 34,678 | 35.3 K to 34.7 K (-1.86 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.58 | 275 | 5,660 | 35,337 | 35.6 K to 35.3 K (-0.77 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.59 | 2,025 | 41,695 | 35,612 | 37.6 K to 35.6 K (-5.38 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.63 | 589 | 12,151 | 37,637 | 38.2 K to 37.6 K (-1.54 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.60 | 3,025 | 62,315 | 38,226 | 41.3 K to 38.2 K (-7.33 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Buy | M | 2.38 | 11,250 | 26,719 | 41,251 | 30 K to 41.3 K (+37.50 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Buy | M | 2.38 | 1,875 | 4,453 | 30,001 | 28.1 K to 30 K (+6.67 %) |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Option Exercise | M | 2.38 | 3,125 | 7,422 | 13,125 | |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Option Exercise | M | 2.38 | 1,875 | 4,453 | 0 | |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 21.00 | 1,000 | 21,001 | 28,126 | 29.1 K to 28.1 K (-3.43 %) |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.82 | 336 | 6,996 | 29,126 | 29.5 K to 29.1 K (-1.14 %) |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.84 | 1,964 | 40,930 | 29,462 | 31.4 K to 29.5 K (-6.25 %) |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 21.17 | 1,700 | 35,989 | 31,426 | 33.1 K to 31.4 K (-5.13 %) |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Buy | M | 2.38 | 3,125 | 7,422 | 33,126 | 30 K to 33.1 K (+10.42 %) |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Buy | M | 2.38 | 1,875 | 4,453 | 30,001 | 28.1 K to 30 K (+6.67 %) |
Nov 15 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Gift | G | 0.00 | 1,200 | 0 | 28,126 | 29.3 K to 28.1 K (-4.09 %) |
Nov 15 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Gift | G | 0.00 | 1,200 | 0 | 29,326 | 30.5 K to 29.3 K (-3.93 %) |
Nov 15 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Gift | G | 0.00 | 1,200 | 0 | 30,526 | 31.7 K to 30.5 K (-3.78 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Option Exercise | M | 2.38 | 18,125 | 43,047 | 1,875 | |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 17.11 | 2,725 | 46,625 | 31,726 | 34.5 K to 31.7 K (-7.91 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 17.50 | 400 | 7,000 | 34,451 | 34.9 K to 34.5 K (-1.15 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 17.30 | 5,000 | 86,500 | 34,851 | 39.9 K to 34.9 K (-12.55 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 17.26 | 4,600 | 79,396 | 39,851 | 44.5 K to 39.9 K (-10.35 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 17.30 | 400 | 6,920 | 44,451 | 44.9 K to 44.5 K (-0.89 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 16.70 | 110 | 1,837 | 44,851 | 45 K to 44.9 K (-0.24 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 16.65 | 4,890 | 81,419 | 44,961 | 49.9 K to 45 K (-9.81 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Buy | M | 2.38 | 18,125 | 43,047 | 49,851 | 31.7 K to 49.9 K (+57.13 %) |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Option Exercise | M | 2.38 | 1,250 | 2,969 | 3,750 | |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Option Exercise | M | 2.38 | 6,875 | 16,328 | 0 | |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Option Exercise | M | 2.38 | 10,000 | 23,750 | 20,000 | |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Buy | M | 2.38 | 1,250 | 2,969 | 31,726 | 30.5 K to 31.7 K (+4.10 %) |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Buy | M | 2.38 | 6,875 | 16,328 | 30,476 | 23.6 K to 30.5 K (+29.13 %) |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Sell | S | 17.50 | 5,000 | 87,500 | 23,601 | 28.6 K to 23.6 K (-17.48 %) |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Sell | S | 17.75 | 5,000 | 88,750 | 28,601 | 33.6 K to 28.6 K (-14.88 %) |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Buy | M | 2.38 | 10,000 | 23,750 | 33,601 | 23.6 K to 33.6 K (+42.37 %) |
Aug 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP& Head ... | Option Exercise | M | 2.38 | 8,125 | 19,297 | 24,375 | |
Aug 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP& Head ... | Option Exercise | M | 2.38 | 10,000 | 23,750 | 30,000 | |
Aug 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP& Head ... | Buy | M | 2.38 | 8,125 | 19,297 | 23,601 | 15.5 K to 23.6 K (+52.50 %) |
Aug 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP& Head ... | Sell | S | 15.30 | 10,000 | 153,000 | 15,476 | 25.5 K to 15.5 K (-39.25 %) |
Aug 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP& Head ... | Buy | M | 2.38 | 10,000 | 23,750 | 25,476 | 15.5 K to 25.5 K (+64.62 %) |
May 11 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP/Head o ... | Sell | S | 21.01 | 5,000 | 105,050 | 15,476 | 20.5 K to 15.5 K (-24.42 %) |
Feb 25 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Option Exercise | A | 23.29 | 10,000 | 232,900 | 10,000 | |
Feb 10 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP/Head o ... | Sell | S | 20.58 | 5,000 | 102,875 | 20,476 | 25.5 K to 20.5 K (-19.63 %) |
Feb 09 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP, Head of Re ... | Buy | J | 17.35 | 399 | 6,923 | 25,476 | 25.1 K to 25.5 K (+1.59 %) |
Dec 03 2003 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP/Head o ... | Sell | S | 20.20 | 5,000 | 101,000 | 25,077 | 30.1 K to 25.1 K (-16.62 %) |
Nov 13 2003 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec. VP & Head of ... | Option Exercise | A | 17.67 | 12,000 | 212,040 | 12,000 | |
Oct 03 2003 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP | Sell | S | 20.01 | 5,000 | 100,050 | 30,077 | 35.1 K to 30.1 K (-14.25 %) |